Go Back
The Column Group
The Column Group, based in San Francisco, is a venture fund specializing in healthcare and life sciences. Founded in 2006, the fund, led by Partner Peter Svennilson, focuses on Pre-Seed to Series D stages. With 99 investments and 18 exits, The Column Group supports companies like Hexagon Bio, Accent Therapeutics, Casma Therapeutics, A2 Biotherapeutics, and Ribon Therapeutics. For more information, visit their website at www.thecolumngroup.com.
About
About
About
Bio
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
Location
San Francisco
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Peter Svennilson
Bio
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
Location
San Francisco
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Peter Svennilson
Fund
Fund
Fund
Fund Focus
Healthcare, Life Science
Number of investments
99
Number of exits
18
Fund Type
Venture Fund
Portfolio Companies
Hexagon Bio, Accent Therapeutics, Casma Therapeutics, A2 Biotherapeutics, Ribon Therapeutics
The Column Group
The Column Group, based in San Francisco, is a venture fund specializing in healthcare and life sciences. Founded in 2006, the fund, led by Partner Peter Svennilson, focuses on Pre-Seed to Series D stages. With 99 investments and 18 exits, The Column Group supports companies like Hexagon Bio, Accent Therapeutics, Casma Therapeutics, A2 Biotherapeutics, and Ribon Therapeutics. For more information, visit their website at www.thecolumngroup.com.
About
Bio
The Column Group is a venture capital firm dedicated to developing biotechnology companies.
Location
San Francisco
Stage
Pre-Seed, Seed, Series A, Series B, Series C, Series D
Partner name
Peter Svennilson
Fund
Fund Focus
Healthcare, Life Science
Number of investments
99
Number of exits
18
Fund Type
Venture Fund
Portfolio Companies
Hexagon Bio, Accent Therapeutics, Casma Therapeutics, A2 Biotherapeutics, Ribon Therapeutics